
Benzinga Pro data, Akoya Biosciences (NASDAQ:AKYA) reported Q4 sales of $16.16 million. Earnings fell to a loss of $17.67 million, resulting in a 52.13% decrease from last quarter. Akoya Biosciences collected $13.48 million in revenue during Q3, but reported earnings showed a $11.62 million loss.